4.2 Article

Spiramyin-loaded PLGA implants for the treatment of ocular toxoplasmosis: development, characterization, biocompatibility, and anti-toxoplasma activity

期刊

PHARMAZIE
卷 76, 期 2-3, 页码 68-76

出版社

AVOXA-MEDIENGRUPPE DEUTSCHER APOTHEKER GMBH
DOI: 10.1691/ph.2021.0100

关键词

-

资金

  1. CNPq (Brasilia, Brazil) [302671/2018-8]
  2. CAPES (Brasilia, Brazil)
  3. FAPEMIG (Minas Gerais, Brazil)
  4. UFOP (Minas Gerais, Brazil)
  5. UFSJ (Minas Gerais, Brazil)

向作者/读者索取更多资源

A study developed spiramycin-loaded PLGA implants for the treatment of ocular toxoplasmosis, demonstrating good ocular biocompatibility and in vitro efficacy against Toxoplasma gondii.
Ocular toxoplasmosis is the major cause of infectious posterior uveitis worldwide, inducing visual field defect and/or blindness. Despite the severity of this disease, an effective treatment is still lacking. In this study, spiramycin-loaded PLGA implants were developed aiming at the treatment of ocular toxoplasmosis. Implants were manufactured by a hot-molding technique, characterized by Fourier Transform Infrared Spectroscopy, X-Ray Diffraction, Differential Scanning Calorimetry, Scanning Electron Microscopy; evaluated in terms of ocular biocompatibility by immunofluorescence, flow cytometry, cell migration, Hen's egg test-chorioallantoic membrane (HET-CAM) irritation test; and investigated in terms of in vitro efficacy against Toxoplasma gondii. Characterization techniques indicated that spiramycin was dispersed into the polymeric chains and both substances preserved their physical structures in implants. The HET-CAM test indicated that implants did not induce hemorrhage or coagulation, being non-irritant to the CAM. ARPE-19 cells showed viability by MTT assay, and normality in cell cycle kinetics and morphology, without stimulating cell death by apoptosis. Finally, they were highly effective against intracellular parasites without inducing human retinal pigment epithelial cell death. In conclusion, spiramycin-loaded PLGA implants represent a promising therapeutic alternative for the local treatment of ocular toxoplasmosis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据